Aspect Biosystems Raises US$115 Million Series B Financing to Advance Bioprinted Tissue Therapeutics
VANCOUVER, British Columbia--(BUSINESS WIRE)--Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics as a new category in regenerative medicine, today ...
Jan 20 (Reuters) - Danish drugmaker Novo Nordisk and Canada-based privately held Aspect Biosystems said on Tuesday they have ...
Stocktwits on MSN
Novo Nordisk inks deal with Canada’s Aspect Biosystems to find more diabetes meds besides Ozempic
Novo and Aspect have been collaborating since 2023 to develop cellular medicines. ・Under the deal, Aspect has acquired rights ...
Contact center and workforce optimization (WFO) provider Aspect Software this morning announced that it will merge with contact center provider Noble Systems to form Alvaria. The new Alvaria will ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, today announced that it has received a $72.75 ...
Zacks Investment Research on MSN
NVO expands Aspect tie-up to advance curative diabetes cell therapies
Novo Nordisk NVO and Aspect Biosystems announced that they are advancing their partnership into a new phase focused on developing next-generation cellular medicines for diabetes. The companies have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results